Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Marczyk

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Cancers|April 3, 2020
Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck CancerKimi Drobin, Michal Marczyk, Martin Halle, et al.
Journal of the American Society of Cytopathology|December 12, 2024
Comparative analysis of Ficoll-Hypaque and CytoLyt techniques for blood removal in breast cancer malignant effusions: effects on RNA quality and sequencing outcomesGloria H Sura, Kevin Tran, Alexander J Trevarton, et al.
NPJ Breast Cancer|July 22, 2022
Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancerMichal Marczyk, Tao Qing, Tess O'Meara, et al.
Breast Cancer Research and Treatment|August 23, 2024
Phosphoenolpyruvate carboxykinase-2 (PCK2) is a therapeutic target in triple-negative breast cancerVignesh Gunasekharan, Hao-Kuen Lin, Michal Marczyk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2024
Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast CancersAlejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, et al.
European Journal of Breast Health|June 19, 2026
Patient-centric Development of Shared Decision-making Aids: The ASSESS Online Personalized Early Breast Cancer Treatment Decision Support Tool and Resource WebsiteBethany A Kerr, J Doug Alexander, Hui Zhao, et al.
Cancer Research|March 5, 2022
Comprehensive Analysis of Metabolic Isozyme Targets in CancerMichal Marczyk, Vignesh Gunasekharan, David Casadevall, et al.
NPJ Breast Cancer|February 9, 2021
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancerJulia Foldi, Andrea Silber, Emily Reisenbichler, et al.
NPJ Breast Cancer|February 4, 2022
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancerJulia Foldi, Andrea Silber, Emily Reisenbichler, et al.
Scientific Data|June 2, 2023
POLCOVID: a multicenter multiclass chest X-ray database (Poland, 2020-2021)Aleksandra Suwalska, Joanna Tobiasz, Wojciech Prazuch, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Cancers|April 3, 2020
Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck CancerKimi Drobin, Michal Marczyk, Martin Halle, et al.
Journal of the American Society of Cytopathology|December 12, 2024
Comparative analysis of Ficoll-Hypaque and CytoLyt techniques for blood removal in breast cancer malignant effusions: effects on RNA quality and sequencing outcomesGloria H Sura, Kevin Tran, Alexander J Trevarton, et al.
NPJ Breast Cancer|July 22, 2022
Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancerMichal Marczyk, Tao Qing, Tess O'Meara, et al.
Breast Cancer Research and Treatment|August 23, 2024
Phosphoenolpyruvate carboxykinase-2 (PCK2) is a therapeutic target in triple-negative breast cancerVignesh Gunasekharan, Hao-Kuen Lin, Michal Marczyk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2024
Hormone Receptor-Positive HER2-Negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple-Negative Breast CancersAlejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, et al.
European Journal of Breast Health|June 19, 2026
Patient-centric Development of Shared Decision-making Aids: The ASSESS Online Personalized Early Breast Cancer Treatment Decision Support Tool and Resource WebsiteBethany A Kerr, J Doug Alexander, Hui Zhao, et al.
Cancer Research|March 5, 2022
Comprehensive Analysis of Metabolic Isozyme Targets in CancerMichal Marczyk, Vignesh Gunasekharan, David Casadevall, et al.
NPJ Breast Cancer|February 9, 2021
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancerJulia Foldi, Andrea Silber, Emily Reisenbichler, et al.
NPJ Breast Cancer|February 4, 2022
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancerJulia Foldi, Andrea Silber, Emily Reisenbichler, et al.
Scientific Data|June 2, 2023
POLCOVID: a multicenter multiclass chest X-ray database (Poland, 2020-2021)Aleksandra Suwalska, Joanna Tobiasz, Wojciech Prazuch, et al.
Pageof 6